World Homoeopathy Day spotlights AYUSH institutions
A backgrounder that maps homoeopathy's statutory regulator, its research body and the AYUSH scheme family ahead of the 10 April observance.
What happened
- The Ministry of AYUSH released a backgrounder on World Homoeopathy Day 2026, observed each year on 10 April to mark the birth anniversary of Dr. Samuel Hahnemann, the founder of homoeopathy.
- The 2026 theme is "Homoeopathy for Sustainable Health", framing the system as a holistic, cost-effective and environmentally responsible approach aligned with Universal Health Coverage and SDG 3 (Good Health and Well-being).
- The formal commemoration is set for 10 April at Vigyan Bhawan, New Delhi, anchored by a two-day interactive forum organised by the Central Council for Research in Homoeopathy (CCRH).
- The backgrounder is, in effect, a single-page revision of the entire homoeopathy governance stack: the workforce numbers, the NCH Act 2020 regulator, the CCRH research body, the PCIM&H pharmacopoeia office and the AYUSH schemes that fund the sector.
- It records that India holds one of the largest homoeopathic workforces in the world — 3.45 lakh registered doctors, 8,593 dispensaries, 277 educational institutions and 34 research centres.
Background & context
Homoeopathy is one of the five recognised AYUSH systems — Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy — that the Government of India treats as a distinct stream of traditional and complementary medicine. The day exists because the system has a single, datable founder. Samuel Hahnemann (1755–1843) was a German physician who formalised the method in 1796; his foundational text, the Organon of Medicine, still guides practice. The word itself comes from the Greek Homois (similar) and Pathos (suffering) — medicine that treats a disease using a substance that, in a healthy person, would produce symptoms similar to the disease.
The system rests on two stated principles. The first, "like cures like" (similia similibus curentur), holds that a substance causing symptoms in a healthy person can, in minute form, treat similar symptoms in a sick one. The second, the "law of minimum dose", holds that the lower the dose, the greater the claimed therapeutic effect — remedies are highly diluted through serial dilution and succussion (vigorous shaking), and are drawn from natural plant, mineral and animal sources. A defining feature is its individualised approach: the remedy is matched to the whole symptom-picture of the person, not a single named disease.
Homoeopathy reached India early. John Martin Honigberger, a disciple of Hahnemann, began practising around 1810; his treatment of Maharaja Ranjit Singh in 1839 raised the system's standing. One of the earliest homoeopathic hospitals was established at Tanjore (Thanjavur), Tamil Nadu, in 1847, and the system was championed in Bengal by Rajendra Lal Dutta and Mahendra Lal Sircar. After Independence the institutional scaffolding was built in two steps that students must keep distinct: the Central Council of Homoeopathy in 1973 (the education/registration regulator) and the Central Council for Research in Homoeopathy in 1978 (the research body). That 1973 regulator was later dissolved and replaced — the central fact this backgrounder is built around.
For Prelims
- World Homoeopathy Day: 10 April · birth anniversary of Samuel Hahnemann (1755–1843) · 2026 theme "Homoeopathy for Sustainable Health" · linked to UHC and SDG 3.
- National Commission for Homoeopathy (NCH): the statutory regulator, set up under the NCH Act, 2020, which came into force on 5 July 2021. On that date the Board of Governors and the older Central Council of Homoeopathy (under the Homoeopathy Central Council Act, 1973) were dissolved.
- NCH functions: regulates homoeopathic education and institutions, sets curriculum and academic standards, maintains the national register of practitioners, enforces professional ethics, and coordinates with state councils.
- Central Council for Research in Homoeopathy (CCRH): the apex research body, headquartered in New Delhi, established 1978; research runs through a network of 33 institutes/units across India, covering drug proving, validation, standardisation and clinical research.
- PCIM&H (Pharmacopoeia Commission for Indian Medicine & Homoeopathy): a subordinate office of the Ministry of AYUSH; builds pharmacopoeias and formularies and acts as the Central Drug Testing-cum-Appellate Laboratory. Set up as PCIM on 18 August 2010; renamed PCIM&H on 20 March 2014 when Homoeopathy was added.
- Ministry of AYUSH: created as a full ministry in 2014 (upgraded from the Department of AYUSH); it is the nodal ministry for all five AYUSH systems including homoeopathy.
- Two principles: "like cures like" and the "law of minimum dose" (high dilution) · medicines drawn from plant, mineral and animal sources via dilution and succussion.
- India's footprint: homoeopathy entered India c. 1810 · 3.45 lakh registered doctors · 8,593 dispensaries · 277 educational institutions · 34 research centres.
- Medicinal plants: India's 7,000–7,500 medicinal plant species are supported through the National Medicinal Plants Board (NMPB) under AYUSH.
The full AYUSH scheme set
Because "how many of these / match the pairs" questions live in the scheme list, the backgrounder names the homoeopathy-supporting schemes explicitly. Carry the complete set:
- National AYUSH Mission (NAM): a centrally-sponsored scheme that integrates AYUSH into mainstream healthcare through co-location at PHCs/CHCs; over 1,84,235 Ayushman Arogya Mandirs (the rebranded AYUSH/Health & Wellness Centres) operationalised.
- AYURSWASTHYA Yojana: supports Centres of Excellence and AYUSH & Public Health activities.
- AYURGYAN Scheme: capacity-building, continuing medical education and research; the Extra Mural Research (EMR) component supports projects up to ₹70 lakh for 2–3 years.
- AOGUSY: the central-sector scheme regulating the quality of ASU&H medicines (Ayurveda, Siddha, Unani, Homoeopathy) under the Drugs & Cosmetics Act, 1940.
- NMPB: the National Medicinal Plants Board supports cultivation of India's 7,000–7,500 medicinal plant species — the raw-material base for AYUSH formulations.
Why it matters
The day is a hook, but the examinable substance is the governance architecture of a recognised system of medicine. Homoeopathy in India is large enough — 3.45 lakh registered practitioners and a national network of dispensaries, colleges and research units — that its regulation is a live question of public health governance, professional standards and consumer protection. The shift from the 1973 Council to the 2020 Commission is the same reform logic that produced the National Medical Commission: replacing an elected-council model criticised for capture with a leaner, nominated commission meant to raise academic standards, clean up the register of practitioners and tighten ethics. That is precisely the kind of "government policy and intervention for development in the health sector" the syllabus tests.
The 2026 framing — "Homoeopathy for Sustainable Health" — also ties the system to two larger debates: the integration of traditional medicine into mainstream healthcare (co-location at health centres, the Ayushman Arogya Mandir network) and the quality-and-evidence question that surrounds AYUSH systems. The backgrounder is candid that the work ahead is "strengthening scientific validation, ethical standards, and integration," which is itself an admission that evidence standardisation is the system's open problem — a useful, source-anchored way-forward and problematisation for an answer.
Finally, the schemes attach homoeopathy to India's medicinal-plants economy and biodiversity: with 7,000–7,500 species supported through the NMPB and an explicit "eco-friendly pharmaceutical practices" and "biodiversity conservation" framing, the sector links health policy to conservation and to the traditional-knowledge debate — the same terrain as the Biological Diversity Act and access-and-benefit-sharing.
For Mains
Related: AYUSH systems hub · Schemes & Welfare · This week's cards